Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities.
Identifieur interne : 000306 ( Pmc/Checkpoint ); précédent : 000305; suivant : 000307Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities.
Auteurs : N Foster ; S. Gilman ; S. Berent ; A Sima ; C. D ; R Koeppe ; S HicksSource :
- Journal of Neurology, Neurosurgery, and Psychiatry [ 0022-3050 ] ; 1992.
Abstract
In studies of cerebral glucose metabolism utilising positron emission tomography (PET) with 18F-fluoro-2-deoxy-D-glucose, patients with the clinical picture of progressive supranuclear palsy (PSP) have shown predominantly frontal glucose hypometabolism. This is presumed to represent deafferentation of cerebral cortical from subcortical structures. In these studies, however, the diagnosis of PSP has not been verified by pathological examination. Necropsy examinations were performed in three patients with the clinical features of PSP in whom PET had demonstrated predominantly frontal hypometabolism. In two of these patients the diagnosis of PSP was confirmed pathologically, and no morphological abnormalities were found in the cerebral cortex. The third patient had extensive cortical and subcortical neuronal loss and gliosis without neurofibrillary tangles, consistent with the diagnosis of progressive subcortical gliosis (PSG). Even in retrospect no unique clinical neurological abnormality or finding on laboratory investigation could be identified that distinguished this latter patient from those with pathologically confirmed PSP. We conclude that PSG and PSP may be indistinguishable during life, and necropsy confirmation is needed for definite diagnosis.
Url:
PubMed: 1527543
PubMed Central: 489210
Affiliations:
Links toward previous steps (curation, corpus...)
Links to Exploration step
PMC:489210Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities.</title>
<author><name sortKey="Foster, N L" sort="Foster, N L" uniqKey="Foster N" first="N" last="Foster">N Foster</name>
</author>
<author><name sortKey="Gilman, S" sort="Gilman, S" uniqKey="Gilman S" first="S" last="Gilman">S. Gilman</name>
</author>
<author><name sortKey="Berent, S" sort="Berent, S" uniqKey="Berent S" first="S" last="Berent">S. Berent</name>
</author>
<author><name sortKey="Sima, A A" sort="Sima, A A" uniqKey="Sima A" first="A" last="Sima">A Sima</name>
</author>
<author><name sortKey="D Amato, C" sort="D Amato, C" uniqKey="D Amato C" first="C" last="D">C. D</name>
</author>
<author><name sortKey="Koeppe, R A" sort="Koeppe, R A" uniqKey="Koeppe R" first="R" last="Koeppe">R Koeppe</name>
</author>
<author><name sortKey="Hicks, S P" sort="Hicks, S P" uniqKey="Hicks S" first="S" last="Hicks">S Hicks</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PMC</idno>
<idno type="pmid">1527543</idno>
<idno type="pmc">489210</idno>
<idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC489210</idno>
<idno type="RBID">PMC:489210</idno>
<date when="1992">1992</date>
<idno type="wicri:Area/Pmc/Corpus">000056</idno>
<idno type="wicri:Area/Pmc/Curation">000056</idno>
<idno type="wicri:Area/Pmc/Checkpoint">000306</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities.</title>
<author><name sortKey="Foster, N L" sort="Foster, N L" uniqKey="Foster N" first="N" last="Foster">N Foster</name>
</author>
<author><name sortKey="Gilman, S" sort="Gilman, S" uniqKey="Gilman S" first="S" last="Gilman">S. Gilman</name>
</author>
<author><name sortKey="Berent, S" sort="Berent, S" uniqKey="Berent S" first="S" last="Berent">S. Berent</name>
</author>
<author><name sortKey="Sima, A A" sort="Sima, A A" uniqKey="Sima A" first="A" last="Sima">A Sima</name>
</author>
<author><name sortKey="D Amato, C" sort="D Amato, C" uniqKey="D Amato C" first="C" last="D">C. D</name>
</author>
<author><name sortKey="Koeppe, R A" sort="Koeppe, R A" uniqKey="Koeppe R" first="R" last="Koeppe">R Koeppe</name>
</author>
<author><name sortKey="Hicks, S P" sort="Hicks, S P" uniqKey="Hicks S" first="S" last="Hicks">S Hicks</name>
</author>
</analytic>
<series><title level="j">Journal of Neurology, Neurosurgery, and Psychiatry</title>
<idno type="ISSN">0022-3050</idno>
<idno type="e-ISSN">1468-330X</idno>
<imprint><date when="1992">1992</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass></textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p>In studies of cerebral glucose metabolism utilising positron emission tomography (PET) with 18F-fluoro-2-deoxy-D-glucose, patients with the clinical picture of progressive supranuclear palsy (PSP) have shown predominantly frontal glucose hypometabolism. This is presumed to represent deafferentation of cerebral cortical from subcortical structures. In these studies, however, the diagnosis of PSP has not been verified by pathological examination. Necropsy examinations were performed in three patients with the clinical features of PSP in whom PET had demonstrated predominantly frontal hypometabolism. In two of these patients the diagnosis of PSP was confirmed pathologically, and no morphological abnormalities were found in the cerebral cortex. The third patient had extensive cortical and subcortical neuronal loss and gliosis without neurofibrillary tangles, consistent with the diagnosis of progressive subcortical gliosis (PSG). Even in retrospect no unique clinical neurological abnormality or finding on laboratory investigation could be identified that distinguished this latter patient from those with pathologically confirmed PSP. We conclude that PSG and PSP may be indistinguishable during life, and necropsy confirmation is needed for definite diagnosis.</p>
<sec sec-type="scanned-figures"><title>Images</title>
<fig id="F1"><graphic xlink:href="jnnpsyc00493-0076-a" xlink:role="710"></graphic>
</fig>
<fig id="F2"><graphic xlink:href="jnnpsyc00493-0076-b" xlink:role="710"></graphic>
</fig>
<fig id="F3"><graphic xlink:href="jnnpsyc00493-0076-c" xlink:role="710"></graphic>
</fig>
<fig id="F4"><graphic xlink:href="jnnpsyc00493-0077-a" xlink:role="711"></graphic>
</fig>
<fig id="F5"><graphic xlink:href="jnnpsyc00493-0077-b" xlink:role="711"></graphic>
</fig>
</sec>
</div>
</front>
</TEI>
<pmc article-type="research-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">J Neurol Neurosurg Psychiatry</journal-id>
<journal-title>Journal of Neurology, Neurosurgery, and Psychiatry</journal-title>
<issn pub-type="ppub">0022-3050</issn>
<issn pub-type="epub">1468-330X</issn>
</journal-meta>
<article-meta><article-id pub-id-type="pmid">1527543</article-id>
<article-id pub-id-type="pmc">489210</article-id>
<article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject>
</subj-group>
</article-categories>
<title-group><article-title>Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities.</article-title>
</title-group>
<contrib-group><contrib contrib-type="author"><name><surname>Foster</surname>
<given-names>N L</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Gilman</surname>
<given-names>S</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Berent</surname>
<given-names>S</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Sima</surname>
<given-names>A A</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>D'Amato</surname>
<given-names>C</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Koeppe</surname>
<given-names>R A</given-names>
</name>
</contrib>
<contrib contrib-type="author"><name><surname>Hicks</surname>
<given-names>S P</given-names>
</name>
</contrib>
</contrib-group>
<aff>Department of Neurology, University of Michigan Medical Center, Ann Arbor 48109-0316.</aff>
<pub-date pub-type="ppub"><month>8</month>
<year>1992</year>
</pub-date>
<volume>55</volume>
<issue>8</issue>
<fpage>707</fpage>
<lpage>713</lpage>
<abstract><p>In studies of cerebral glucose metabolism utilising positron emission tomography (PET) with 18F-fluoro-2-deoxy-D-glucose, patients with the clinical picture of progressive supranuclear palsy (PSP) have shown predominantly frontal glucose hypometabolism. This is presumed to represent deafferentation of cerebral cortical from subcortical structures. In these studies, however, the diagnosis of PSP has not been verified by pathological examination. Necropsy examinations were performed in three patients with the clinical features of PSP in whom PET had demonstrated predominantly frontal hypometabolism. In two of these patients the diagnosis of PSP was confirmed pathologically, and no morphological abnormalities were found in the cerebral cortex. The third patient had extensive cortical and subcortical neuronal loss and gliosis without neurofibrillary tangles, consistent with the diagnosis of progressive subcortical gliosis (PSG). Even in retrospect no unique clinical neurological abnormality or finding on laboratory investigation could be identified that distinguished this latter patient from those with pathologically confirmed PSP. We conclude that PSG and PSP may be indistinguishable during life, and necropsy confirmation is needed for definite diagnosis.</p>
<sec sec-type="scanned-figures"><title>Images</title>
<fig id="F1"><graphic xlink:href="jnnpsyc00493-0076-a" xlink:role="710"></graphic>
</fig>
<fig id="F2"><graphic xlink:href="jnnpsyc00493-0076-b" xlink:role="710"></graphic>
</fig>
<fig id="F3"><graphic xlink:href="jnnpsyc00493-0076-c" xlink:role="710"></graphic>
</fig>
<fig id="F4"><graphic xlink:href="jnnpsyc00493-0077-a" xlink:role="711"></graphic>
</fig>
<fig id="F5"><graphic xlink:href="jnnpsyc00493-0077-b" xlink:role="711"></graphic>
</fig>
</sec>
</abstract>
</article-meta>
</front>
</pmc>
<affiliations><list></list>
<tree><noCountry><name sortKey="Berent, S" sort="Berent, S" uniqKey="Berent S" first="S" last="Berent">S. Berent</name>
<name sortKey="D Amato, C" sort="D Amato, C" uniqKey="D Amato C" first="C" last="D">C. D</name>
<name sortKey="Foster, N L" sort="Foster, N L" uniqKey="Foster N" first="N" last="Foster">N Foster</name>
<name sortKey="Gilman, S" sort="Gilman, S" uniqKey="Gilman S" first="S" last="Gilman">S. Gilman</name>
<name sortKey="Hicks, S P" sort="Hicks, S P" uniqKey="Hicks S" first="S" last="Hicks">S Hicks</name>
<name sortKey="Koeppe, R A" sort="Koeppe, R A" uniqKey="Koeppe R" first="R" last="Koeppe">R Koeppe</name>
<name sortKey="Sima, A A" sort="Sima, A A" uniqKey="Sima A" first="A" last="Sima">A Sima</name>
</noCountry>
</tree>
</affiliations>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/JankovicV1/Data/Pmc/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000306 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd -nk 000306 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Santé |area= JankovicV1 |flux= Pmc |étape= Checkpoint |type= RBID |clé= PMC:489210 |texte= Progressive subcortical gliosis and progressive supranuclear palsy can have similar clinical and PET abnormalities. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Checkpoint/RBID.i -Sk "pubmed:1527543" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Checkpoint/biblio.hfd \ | NlmPubMed2Wicri -a JankovicV1
![]() | This area was generated with Dilib version V0.6.19. | ![]() |